By 2035, the Neuromyelitis Optica Spectrum Disorder Treatment Market is estimated to expand to USD 1249.55 Million, showcasing a robust CAGR of 6.42% between 2025 and 2035, starting from a valuation of USD 630.23 Million in 2024.
read more..